当前位置:首页 - 行情中心 - 四环生物(000518) - 财务分析 - 现金流量表

四环生物

(000518)

  

流通市值:31.30亿  总市值:31.30亿
流通股本:10.30亿   总股本:10.30亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金119,016,566.9567,817,340.6531,852,385.66302,321,704.2
  收到的税费返还16,909.48006,960.92
  收到其他与经营活动有关的现金1,461,438.43801,009.81255,449.263,198,367.61
  经营活动现金流入小计120,494,914.8668,618,350.4632,107,834.92305,527,032.73
  购买商品、接受劳务支付的现金47,625,319.3115,486,706.216,576,954.7957,606,688.45
  支付给职工以及为职工支付的现金36,536,562.2326,786,028.917,335,742.8648,552,875.54
  支付的各项税费9,222,180.937,261,063.93,718,749.88,056,963.13
  支付其他与经营活动有关的现金51,295,839.1336,353,895.0620,298,379.79113,193,355.49
  经营活动现金流出小计144,679,901.685,887,694.0747,929,827.24227,409,882.61
  经营活动产生的现金流量净额-24,184,986.74-17,269,343.61-15,821,992.3278,117,150.12
二、投资活动产生的现金流量:
  收回投资收到的现金0001,500,000
  处置固定资产、无形资产和其他长期资产收回的现金净额00092,000
  处置子公司及其他营业单位收到的现金净额457,226.35457,226.359,257.755,028.64
  投资活动现金流入小计457,226.35457,226.359,257.751,597,028.64
  购建固定资产、无形资产和其他长期资产支付的现金5,632,286.533,350,140.971,027,2063,595,542.39
  取得子公司及其他营业单位支付的现金70,046,689.28000
  投资活动现金流出小计75,678,975.813,350,140.971,027,2063,595,542.39
  投资活动产生的现金流量净额-75,221,749.46-2,892,914.62-1,017,948.25-1,998,513.75
三、筹资活动产生的现金流量:
  取得借款收到的现金74,800,00010,000,00010,000,00010,000,000
  收到其他与筹资活动有关的现金30,000,0000040,000,000
  筹资活动现金流入小计104,800,00010,000,00010,000,00050,000,000
  偿还债务支付的现金0009,470,000
  分配股利、利润或偿付利息支付的现金822,678.57515,733.08235,444.93575,196.64
  支付其他与筹资活动有关的现金8,808,091.958,383,311.757,996,569.544,341,012.46
  筹资活动现金流出小计9,630,770.528,899,044.838,232,014.4354,386,209.1
  筹资活动产生的现金流量净额95,169,229.481,100,955.171,767,985.57-4,386,209.1
四、汇率变动对现金及现金等价物的影响-49,729.72-42,734.61-28,861.44-34,676.79
五、现金及现金等价物净增加额-4,287,236.44-19,104,037.67-15,100,816.4471,697,750.48
  加:期初现金及现金等价物余额79,691,991.5779,691,991.5779,691,991.577,994,241.09
  期末现金及现金等价物余额75,404,755.1360,587,953.964,591,175.1379,691,991.57
补充资料:
  净利润--28,440,705.84--39,610,830.88
  资产减值准备--1,890,392.82-3,161,087.42
  固定资产和投资性房地产折旧-5,174,555.33-10,976,980.28
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-5,174,555.33-10,976,980.28
  无形资产摊销-614,724.95-1,497,224.08
  长期待摊费用摊销-0-0
  处置固定资产、无形资产和其他长期资产的损失-0-762,757.42
  固定资产报废损失-825-611,552.3
  公允价值变动损失--51,996.85-31,491.05
  财务费用-1,003,530.87-1,687,076.68
  投资损失-0--3,557,542.6
  递延所得税-226,321.69--1,313,755.37
  其中:递延所得税资产减少-226,321.69--1,313,755.37
    递延所得税负债增加-0-0
  存货的减少-53,454,046.28-137,844,385.42
  经营性应收项目的减少--32,787,119.58--13,101,336.05
  经营性应付项目的增加--17,251,427.56--36,259,862.21
  其他-0-0
  债务转为资本-0-0
  一年内到期的可转换公司债券-0-0
  融资租入固定资产-0-0
  现金的期末余额-60,587,953.9-79,691,991.57
  减:现金的期初余额-79,691,991.57-7,994,241.09
  加:现金等价物的期末余额-0-0
  减:现金等价物的期初余额-0-0
  现金及现金等价物的净增加额--19,104,037.67-71,697,750.48
公告日期2026-10-302026-08-212026-04-272026-04-18
审计意见(境内)标准无保留意见
TOP↑